Pin1 as a Central Modulator of Wnt/β-Catenin Signaling in Pulmonary Fibrosis: Interplay with EBV-LMP1 and Therapeutic Implications

Pin1 is a critical regulator of the Wnt/β-catenin pathway in PF, integrating signals from viral and cellular modulators. This study provides novel evidence of EBV-LMP1's role in activating Pin1 in lung fibroblasts, reinforcing its value as a therapeutic target. Pin1 inhibitors effectively downregulate this signaling cascade, even under hyperactive conditions, highlighting their therapeutic potential for PF treatment. While Pin1 inhibitors effectively downregulate this signaling cascade even under hyperactive conditions, their therapeutic potential remains to be validated in preclinical models.

Authors

Institutions

Publication Details

Journal
Iranian journal of pharmaceutical research
Published
2025-12-08
DOI
https://doi.org/10.5812/ijpr-160860
Primary Topic
Signaling Pathways in Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pin1 as a Central Modulator of Wnt/β-Catenin Signaling in Pulmonary Fibrosis: Interplay with EBV-LMP1 and Therapeutic Implications

Yadong Yuan, Hong Jiang Yan, Jin Yingli, Yanchao Liu et al.
Iranian journal of pharmaceutical research
Signaling Pathways in Disease
article

Pin1 as a Central Modulator of Wnt/β-Catenin Signaling in Pulmonary Fibrosis: Interplay with EBV-LMP1 and Therapeutic Implications

Yadong Yuan, Hong Jiang Yan, Jin Yingli, Yanchao Liu, Pei Wang, Xiaodan Jiao
article en

Abstract

Pin1 is a critical regulator of the Wnt/β-catenin pathway in PF, integrating signals from viral and cellular modulators. This study provides novel evidence of EBV-LMP1's role in activating Pin1 in lung fibroblasts, reinforcing its value as a therapeutic target. Pin1 inhibitors effectively downregulate this signaling cascade, even under hyperactive conditions, highlighting their therapeutic potential for PF treatment. While Pin1 inhibitors effectively downregulate this signaling cascade even under hyperactive conditions, their therapeutic potential remains to be validated in preclinical models.

Iranian journal of pharmaceutical researchVol. 24(1)
Hebei Medical University (CN), Second Hospital of Hebei Medical University (CN)
Openalex Percentile: Top 36%
Signaling Pathways in Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.